Safety and Effectiveness of Probiotics in Preterm Infants with Necrotizing Enterocolitis

Laura N Calvo1, Rachel G Greenberg1,2, Keyaria D Gray1

  • 1Department of Pediatrics, Duke University School of Medicine, Durham, NC.

Neoreviews
|March 31, 2024
PubMed

Insights

Necrotizing enterocolitis in preterm infants is linked to gut dysbiosis. Probiotics may help by restoring the gut microbiome, potentially reducing necrotizing enterocolitis rates.

Area of Science:

  • Neonatal medicine
  • Microbiology
  • Gastroenterology

Background:

  • Necrotizing enterocolitis (NEC) is a significant cause of illness and death in premature infants.
  • The exact causes of NEC are unknown, but gut dysbiosis (microbial imbalance) is a suspected factor.
  • Altering the gut microbiome may prevent NEC development.

Approach:

  • This review examines the use of probiotics in neonatal intensive care units (NICUs).
  • We analyze current research on probiotic safety and efficacy.
  • The potential of probiotics to decrease NEC incidence in preterm infants is discussed.

Key Points:

  • Gut dysbiosis is implicated in necrotizing enterocolitis pathogenesis.
  • Probiotics are increasingly used in NICUs to manage the gut microbiome.
  • Evidence on probiotic safety and NEC reduction is under review.

Conclusions:

  • Probiotics represent a potential therapeutic strategy for NEC prevention in preterm infants.
  • Further research is needed to confirm the benefits of probiotics in this vulnerable population.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...